Casodex and Xanthogranuloma - a phase IV clinical study of FDA data

Summary:

We study 10,475 people who take Casodex or have Xanthogranuloma. No report of Xanthogranuloma is found in people who take Casodex.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.


On Nov, 28, 2022

No report is found.


What is Casodex?

Casodex has active ingredients of bicalutamide. It is often used in prostate cancer. eHealthMe is studying from 10,303 Casodex users for its effectiveness, alternative drugs and more.

What is Xanthogranuloma?

Xanthogranuloma (self-limiting tumour with self healing) is found to be associated with 129 drugs and 86 conditions by eHealthMe.

Do you take Casodex and have Xanthogranuloma?

Check whether Xanthogranuloma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Xanthogranuloma and when was it recovered:

Expand to all the drugs that have ingredients of bicalutamide:

Alternative drugs to, pros and cons of Casodex:

Xanthogranuloma treatments and more:

COVID vaccines that are related to Xanthogranuloma:

All the drugs that are associated with Xanthogranuloma:

All the conditions that are associated with Xanthogranuloma:

How the study uses the data?

The study uses data from the FDA. It is based on bicalutamide (the active ingredients of Casodex) and Casodex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: